These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6106702)

  • 1. Use of whole saliva for bioavailability studies with reference to phenytoin.
    Paxton JW; Wilcox JB
    J Pharm Pharmacol; 1980 Aug; 32(8):586-8. PubMed ID: 6106702
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the bioavailability of Polfa phenytoin tablets].
    Lazowski J; Lypka A; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1978; 12(3):251-5. PubMed ID: 683430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption and metabolism of phenytoin from tablets and capsules.
    Smith TC; Kinkel A
    Clin Pharmacol Ther; 1976 Dec; 20(6):738-42. PubMed ID: 791565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the bioavailability of two brands of phenytoin.
    Gibberd FB; Spencer KM; Webley M; Berry D
    Br J Clin Pharmacol; 1982 Mar; 13(3):455-6. PubMed ID: 7059449
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dissolution rates and bioavailability of phenytoin preparations (author's transl)].
    Brandau R; Wehnert HU
    Arzneimittelforschung; 1979; 29(3):552-5. PubMed ID: 582744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bio-availability and dissolution of three phenytoin preparations for children.
    Hodges S; Forsythe WI; Gillies D; Remington H; Cawood A
    Dev Med Child Neurol; 1986 Dec; 28(6):708-12. PubMed ID: 3817309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability and clinical usefulness of low-strength tablets of phenytoin.
    Mura P; Bramanti G; Liguori A; Polidori G; Santoni G; Landini A; Zaccara G; Muscas GC; Messori A
    Farmaco Prat; 1986 Oct; 41(10):313-25. PubMed ID: 3792533
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of the bioavailability of five different phenytoin preparations.
    Hirji MR; Measuria H; Kuhn S; Mucklow JC
    J Pharm Pharmacol; 1985 Aug; 37(8):570-2. PubMed ID: 2864420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of phenytoin from various pharmaceutical preparations in children.
    Manson JI; Beal SM; Magarey A; Pollard AC; O'Reilly WJ; Sansom LN
    Med J Aust; 1975 Oct; 2(15):590-2. PubMed ID: 1196223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of phenytoin on single and multiple oral doses of two dosage forms in normal subjects.
    Kohda Y; Nishihara K; Isozaki S; Saitoh Y; Nakagawa F; Tamura Z
    J Pharmacobiodyn; 1983 Jan; 6(1):46-55. PubMed ID: 6854522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative bioavailability of phenytoin from generic formulations in the United Kingdom.
    Chen SS; Allen J; Oxley J; Richens A
    Epilepsia; 1982 Apr; 23(2):149-52. PubMed ID: 7075570
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenytoin toxicity when tablets substituted for capsules.
    Kirshner HS
    N Engl J Med; 1983 May; 308(18):1106. PubMed ID: 6835331
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro and in vivo availability of hydrophilized phenytoin from capsules.
    Lerk CF; Lagas M; Lie-a-Huen L; Broersma P; Zuurman K
    J Pharm Sci; 1979 May; 68(5):634-8. PubMed ID: 430506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable-isotope methodology for the bioavailability study of phenytoin during multiple-dosing regimens.
    Kasuya Y; Mamada K; Baba S; Matsukura M
    J Pharm Sci; 1985 May; 74(5):503-7. PubMed ID: 4020625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bioavailability for phenytoin products prepared by wet granulation in normal subjects and epileptic patients.
    Kohda Y; Nishihara K; Saitoh Y; Nakagawa F; Tamura Z; Hosaka A; Ishikawa N
    J Pharmacobiodyn; 1983 Oct; 6(10):752-9. PubMed ID: 6689335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bioavailability of phenytoin.
    Gugler R; Fröscher W; Eichelbaum M; Hildenbrand G
    J Neurol; 1977 Oct; 216(3):155-62. PubMed ID: 72133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of phenytoin availability from pharmaceutical preparations].
    Leucuţa SE; Almaşu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1986; 31(4):273-82. PubMed ID: 2951832
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioavailability of four brands of phenytoin tablets.
    Pentikäinen PJ; Neuvonen PJ; Elfving SM
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):213-8. PubMed ID: 1243985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of phenytoin. A comparison of two preparations.
    Stewart MJ; Ballinger BR; Devlin EJ; Miller AY; Ramsay AC
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):209-12. PubMed ID: 1243984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.